Thieme Chemistry Journals Awardees – Where Are They Now?Chiral Sulfinamide Ligands and Pd-Catalyzed Asymmetric Allylic Alkylations of Ethyl 2-Fluoroacetoacetate

Mingzhu Zhao; Yawei Tian; Xiaoming Zhao

doi:10.1055/s-0036-1589033

Synlett, Table of Contents

Synlett 2017; 28(14): 1801-1806
DOI: 10.1055/s-0036-1589033

letter

Thieme Chemistry Journals Awardees – Where Are They Now?
Chiral Sulfinamide Ligands and Pd-Catalyzed Asymmetric Allylic Alkylations of Ethyl 2-Fluoroacetoacetate

Mingzhu Zhao

^aShanghai Key Lab of Chemical Assessment and Sustainability, School of Chemical Science and Engineering, Tongji University, Shanghai 200092, P. R. of China Email: xmzhao08@mail.tongji.edu.cn

,

Yawei Tian

^aShanghai Key Lab of Chemical Assessment and Sustainability, School of Chemical Science and Engineering, Tongji University, Shanghai 200092, P. R. of China Email: xmzhao08@mail.tongji.edu.cn

,

Xiaoming Zhao*

^aShanghai Key Lab of Chemical Assessment and Sustainability, School of Chemical Science and Engineering, Tongji University, Shanghai 200092, P. R. of China Email: xmzhao08@mail.tongji.edu.cn

^bLaboratory of Organofluorine Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 354 Fenglin Road, Shanghai 200032, P. R. of China

› Author Affiliations

Abstract

All articles of this category

Abstract

New chiral sulfinamide ligands made from salicylic acids and chiral tert-butanesulfinamide was utilized in Pd-catalyzed asymmetric allylic substitutions of ethyl 2-fluoroacetoacetate, which afforded the fluorinated allyl products with up to 98% yield, 94% ee, and 2.2:1 dr. Both sulfoxide and hydroxyl group on the sulfanilamide ligands are crucial for enantiocontrol in the Pd-catalyzed allylic alkylations of ethyl 2-fluoroacetoacetate.

Key words

sulfinamide ligand - allylation - palladium - enantioselectivity - fluorinated allylproduct

Full Text

References

References and Notes

For selected papers, reviews, and books, see:

1a Bégué JP. Bonnet-Delpon D. Bioorganic and Medicinal Chemistry of Fluorine . Wiley; New Jersey: 2008
1b Kirsch P. Modern Fluoroorganic Chemistry: Synthesis, Reactivity, Applications. 2nd ed. Wiley-VCH; Weinheim: 2013
1c Hagmann WK. J. Med. Chem. 2008; 51: 4359
1d Furuya T. Kamlet AS. Ritter T. Nature 2011; 473: 470
1e Liang T. Neumann CN. Ritter T. Angew. Chem. Int. Ed. 2013; 52: 8214
1f Lectard S. Hamashima Y. Sodeoka M. Adv. Synth. Catal. 2010; 352: 2708

2a Chu CK. Cheng YC. Pai BS. Yao GQ. US Patent 5587362, 1996
2b Marcellin P. Mommeja-Marin H. Sacks SL. Lau GK. Sereni D. Bronowicki JP. Mondou E. Hepatology 2004; 40: 140

3 Montgomery JA. Shortnacy-Fowler AT. Clayton SD. Riordan JM. Secrist III JA. J. Med. Chem. 1992; 35: 397
4 Sorbera LA. Serradell N. Bolos J. Drugs Fut. 2007; 32: 12
5 Yamaguchi M. Yasueda SI. Isowaki A. Yamamoto M. Kimura M. Inada K. Ohtori A. Int. J. Pharm. 2005; 301: 121

For selected examples, see:

6a Fukuzumi T. Shibata N. Sugiura M. Yasui H. Nakamura S. Toru T. Angew. Chem. Int. Ed. 2006; 118: 5095
6b Bélanger É. Cantin K. Messe O. Tremblay M. Paquin JF. J. Am. Chem. Soc. 2007; 129: 1034

7 FBSM was reported by Shibata and Hu, respectively, in 2006, see ref. 6a and: Ni C. Li Y. Hu J. J. Org. Chem. 2006; 71: 6829

8a Buchannan RL. Pattison FL. M. Can. J. Chem. 1965; 43: 3466
8b Harsanyi A. Sandford G. Org. Process Res. Dev. 2014; 18: 981

For the use of 2-fluoromalonate in Pd-catalyzed asymmetrical allylations, see:

9a Kawasaki T. Kitazume T. Isr. J. Chem. 1999; 39: 129
9b Jiang B. Huang ZG. Cheng KJ. Tetrahedron: Asymmetry 2006; 17: 942
9c Shibatomi K. Muto T. Sumilkawa Y. Narayama A. Iwasa S. Synlett 2009; 241
9d For the use of FBSM in Pd-catalyzed asymmetrical allylations of symmetric di-substituted allylic substrates, see: Zhao X. Liu D. Zheng S. Gao N. Tetrahedron Lett. 2011; 52: 665

10a Liu WB. Zheng SC. He H. Zhao XM. Dai LX. You SL. Chem. Commun. 2009; 6604
10b Zhang H. Chen J. Zhao XM. Org. Biomol. Chem. 2016; 14: 7183

11 Zhu F. Xu PW. Zhou F. Wang CH. Zhou J. Org. Lett. 2015; 17: 972

12a Han X. Kwiatkowski J. Xue F. Huang KW. Lu Y. Angew. Chem. Int. Ed. 2009; 121: 7740
12b Li H. Zu L. Xie H. Wang W. Synthesis 2009; 1525
12c Yang W. Wei X. Pan Y. Lee R. Zhu B. Liu H. Yan L. Huang KW. Jiang Z. Tan CH. Chem. Eur. J. 2011; 17: 8066
12d Furukawa T. Kawazoe J. Zhang W. Nishimine T. Tokunaga E. Matsumoto T. Shiro M. Shibata N. Angew. Chem. Int. Ed. 2011; 50: 9684
12e Companyó X. Valero G. Ceban V. Calvet T. Font-Bardia M. Moyano A. Rios R. Org. Biomol. Chem. 2011; 9: 7986
12f Wang B. Companyó X. Li J. Moyano A. Rios R. Tetrahedron Lett. 2012; 53: 4124
12g Cosimi E. Engl OD. Saadi J. Ebert MO. Wennemers H. Angew. Chem. Int. Ed. 2016; 55: 13127

For recent reviews, see:

13a Trost BM. Van Vranken DL. Chem. Rev. 1996; 96, 395
13b Johannsen M. Jørgensen KA. Chem. Rev. 1998; 98: 1689
13c Hayashi T. J. Organomet. Chem. 1999; 576: 195
13d Helmchen G. Pfaltz A. Acc. Chem. Res. 2000; 33: 336
13e Dai L.-X. Tu T. You S.-L. Deng W.-P. Hou X.-L. Acc. Chem. Res. 2003; 36: 659
13f Trost BM. Crawley ML. Chem. Rev. 2003; 103: 2921
13g Trost BM. J. Org. Chem. 2004; 69: 5813
13h Trost BM. Machacek MR. Aponick A. Acc. Chem. Res. 2006; 39: 747
13i Lu Z. Ma S. Angew. Chem. Int. Ed. 2008; 47: 258
13j Dieguez M. Pamies O. Acc. Chem. Res. 2010; 43: 312
13k He H. Ye KY. Wu QF. Dai LX. You SL. Adv. Synth. Catal. 2012; 354: 1084
13l Liu WB. Xia JB. You SL. Top. Organomet. Chem. 2012; 38: 155

For selected papers and reviews, see:

14a Glorius F. Angew. Chem. Int. Ed. 2004; 43: 3364
14b Defieber C. Grützmacher H. Carreira EM. Angew. Chem. Int. Ed. 2008; 47: 4482
14c Hayashi T. Aldrichimica Acta 2009; 42: 31
14d Feng CG. Xu MH. Lin GQ. Synlett 2011; 1345

For selected reviews, see:

15a Carreño MC. Chem. Rev. 1995; 95: 1717
15b Fernández I. Khiar N. Chem. Rev. 2003; 103: 3651
15c Robak MT. Herbage MA. Ellman JA. Chem. Rev. 2010; 110: 3600
15d Sipos G. Drinkel EE. Dorta R. Chem. Soc. Rev. 2015; 44: 3834
15e Trost BM. Rao M. Angew. Chem. Int. Ed. 2015; 54: 5026

16a Mariz R. Luan X. Gatti M. Linden A. Dorta R. J. Am. Chem. Soc. 2008; 130: 2172
16b Bürgi JJ. Mariz R. Gatti M. Drinkel E. Luan X. Blumentritt S. Linden A. Dorta R. Angew. Chem. Int. Ed. 2009; 48: 2768

17a Chen J. Lang F. Li D. Cun L. Zhu L. Deng J. Liao J. Tetrahedron: Asymmetry 2009; 20: 1953
17b Liu J. Chen G. Jing X. Liao J. Tetrahedron: Asymmetry 2011; 22: 575
17c Du L. Cao P. Xing J. Lou Y. Jiang L. Li L. Liao J. Angew. Chem. Int. Ed. 2013; 52: 4207

18a Jin SS. Wang H. Xu MH. Chem. Commun. 2011; 7230
18b Jin SS. Wang H. Zhu TS. Xu MH. Org. Biomol. Chem. 2012; 10: 1764

19 Feng X. Wang Y. Wei B. Yang J. Du H. Org. Lett. 2011; 13: 3300
20 Chen Q. Chen C. Guo F. Xia W. Chem. Commun. 2013; 6433

21a Gao N. Zhao XM. Cai CS. Cai JW. Org. Biomol. Chem. 2015; 13: 9551
21b Zhang M. Zhao MZ. Zheng PR. Zhang HB. Zhao XM. J. Fluorine Chem. 2016; 189: 13

22 Typical Procedure for the Synthesis of (R)-L1 To a solution of salicylic acid (1.0 mmol) in THF (2.0 mL) was added 1,1′-carbonyldiimidazole (CDI; 1.0 mmol, 1.0 equiv) slowly at room temperature, then the reaction mixture was heated to 50 °C for 1.0 h. The solution was cooled to room temperature and concentrated to give the active amide. To a suspension of KH (30% in oil, 2.0 mmol, 2.0 equiv) in THF (5.0 mL) was added (R)-tert-butanesulfinamide (1.0 mmol) under argon at room temperature and the mixture was stirred for 0.5 h. The active amide was added and the mixture was stirred at 50 °C for 1.0 h. The reaction mixture was cooled to room temperature and acidified with aqueous HCl to pH >7, then the mixture was diluted with EtOAc (10 mL), washed with H₂O (3 × 10 mL) and brine (10 mL), dried over anhydrous Na₂SO₄, filtered, and concentrated under vacuum. The residue was purified by column chromatography on silica gel (EtOAc) to give the desired product (R)-L1 (149.4 mg, 62% yield) as a white solid; mp 144.6–145.9 °C; [α]_d ²⁵ –73.8 (c = 1.0, MeOH). ¹H NMR (400 MHz, CDCl₃): δ = 7.78 (d, J = 7.8 Hz, 1 H), 7.39 (t, J = 7.4 Hz, 1 H), 7.01 (d, J = 8.1 Hz, 1 H), 6.88 (t, J = 7.5 Hz, 1 H), 1.36 (s, 9 H). ¹³C NMR (100 MHz, CDCl₃): δ = 168.94, 159.16, 135.22, 129.55, 119.79, 118.01, 115.40, 57.05, 22.26. IR (KBr): 3259, 2963, 2930, 2854, 1677, 1605, 1464, 1408, 1393, 1304, 1232, 1107, 1032 cm^–1. HRMS (ESI-TOF): m/z [M + H]⁺ calcd for C₁₁H₁₆NO₃S: 242.0845; found: 242.0841
23 CCDC-1499293, (R)-L1, contains the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/getstructures
24 Takaya H. Mashima K. Koyano K. Yagi M. Kumobayashi H. Taketomi T. Noyori R. J. Org. Chem. 1986; 51: 629
25 Abbenhius HC. L. Burckhardt U. Gramlich V. Kollner C. Pregosin PS. Salzman R. Togni A. Organometallics 1995; 14: 759
26 Trost BM. Van Vranken DL. Bingel C. J. Am. Chem. Soc. 1992; 114: 9327
27 Typical Procedure for Pd-Catalyzed Allylic Alkylation Reaction [Pd(C₃H₅)Cl]₂ (0.004 mmol, 4 mol%), (R)-L1 (0.008 mmol, 8 mol%), and (E)-1,3-disubstituted allyl acetate 1 (0.1 mmol) were dissolved in THF/dioxane (2.0 mL, 1:1) in a dry Schlenk tube filled with argon. The reaction mixture was stirred for 30 min at room temperature, then ethyl 2-fluoroacetoacetate (2a; 0.3 mmol, 3.0 equiv) and K₃PO₄ (0.3 mmol, 3.0 equiv) were added. The reaction mixture was stirred at room temperature and the progress of the reaction was monitored by TLC. Upon completion, the mixture was filtered through Celite and the solvent was evaporated under vacuum. The residue was purified by column chromatography on silica gel (petroleum ether/ethyl acetate) to give the desired products 3a–i. (E)-Ethyl 2-Acetyl-3,5-bis(3-chlorophenyl)-2-fluoropent-4-enoate (3a): Colorless oil (39.8 mg, 98% yield). The diastereomeric ratio was 1.6:1 determined by ¹H NMR spectroscopic analysis. The ee value of the major diastereomer was 80%, the minor diastereomer was 78%, determined by chiral HPLC [Daicel CHIRALCEL OJ-H (0.46 cm × 25 cm); hexane/i-PrOH = 98:2; flow rate = 1.0 mL/min; detection wavelength = 254 nm; t_R (major) = 16.984, 19.423 min; t_R (minor) = 21.968, 25.166 min]. ¹H NMR (400 MHz, CDCl₃, stereoisomeric mixture): δ = 7.42–7.17 (m, 13 H), 6.61–6.21 (m, 3.3 H), 4.52 (dd, J = 32.6, 8.8 Hz, 1.6 H), 4.37–4.16 (m, 2 H), 4.06 (m, 1.3 H), 2.32 (d, J = 5.7 Hz, 1.9 H), 2.01 (d, J = 5.6 Hz, 3 H), 1.27 (t, J = 7.1 Hz, 3 H), 1.06 (t, J = 7.1 Hz, 1.9 H). ¹³C NMR (100 MHz, CDCl₃, stereoisomeric mixture): δ = 201.32 (d, J = 29.8 Hz), 201.14 (d, J = 29.9 Hz), 164.66 (d, J = 25.7 Hz), 164.26 (d, J = 25.9 Hz), 139.01, 138.42, 138.10, 138.03, 134.60, 134.46, 133.61, 133.30, 130.04, 130.02, 129.85, 129.52 (d, J = 2.5 Hz), 129.19 (d, J = 2.6 Hz), 128.11, 128.06, 128.05, 128.00, 127.70 (d, J = 2.2 Hz), 127.12 (d, J = 2.6 Hz), 126.38, 126.33, 125.79, 125.75, 125.60, 125.55, 124.89, 124.80, 102.68 (d, J = 206.1 Hz), 102.52 (d, J = 207.9 Hz), 63.09, 62.84, 52.88 (d, J = 18.1 Hz), 52.82 (d, J = 18.2 Hz), 26.85, 26.84, 14.18, 13.77. ¹⁹F NMR (376 MHz, CDCl₃, stereoisomeric mixture): δ = –174.49, –175.05. IR (KBr): 3064, 2982, 2932, 2854, 1754, 1734, 1594, 1570, 1476, 1431, 1356, 1246, 1205, 967, 913, 781, 742 cm^–1. HRMS (ESI-TOF): m/z [M + Na]⁺ calcd. for C₂₁H₁₉Cl₂FNaO₃: 431.0587; found: 431.0592

For the biological activity and synthesis of β-lactones, see:

28a Hanessian S. Tehim A. Chen P. J. Org. Chem. 1993; 58: 7768
28b Liu DZ. Wang F. Liao TG. Tang JG. Steglich W. Zhu HJ. Liu JK. Org. Lett. 2006; 8: 5749
28c Groll M. Huber R. Potts BC. J. Am. Chem. Soc. 2006; 128: 5136

Supplementary Material

Supporting Information